Jiangsu Recbio Technology Co., Ltd. (2179.HK)

HKD 8.0

(-3.38%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Revenue 30.37 Million 5.32 Million 6.19 Million 1.45 Million -
Cost of Revenue 8.03 Million - - - -
Gross Profit 22.33 Million 5.32 Million 6.19 Million 1.45 Million -
Operating Expenses 640.08 Million 875.07 Million 613.26 Million 147.47 Million 74.79 Million
Selling, General and Administrative Expenses 152.23 Million 163.95 Million 146.5 Million 6.99 Million 3.48 Million
Research and Development Expenses 487.84 Million 716.44 Million 472.95 Million 130.51 Million 63.26 Million
Other Expenses - -5.32 Million -6.19 Million 9.96 Million 8.05 Million
Cost and Expenses 648.12 Million 875.07 Million 613.26 Million 147.47 Million 74.79 Million
Operating Income -617.74 Million -735.96 Million -612.45 Million -147.66 Million -72.75 Million
Interest Expense - 3.53 Million 56.3 Million 37.11 Million 76.16 Million
Income Tax Expense - -16.79 Million 45.1 Million 31.73 Million 65.51 Million
Earnings before Tax -572.44 Million -735.99 Million -657.56 Million -179.4 Million -138.27 Million
Net Income -571.95 Million -719.2 Million -702.67 Million -211.13 Million -203.78 Million
Earnings Per Share Basic -1.19 -1.52 -1.57 -0.44 -0.43
Earnings Per Share Diluted -1.19 -1.52 -1.57 -0.44 -0.43
Weighted Average Shares Outstanding 480.94 Million 474.21 Million 448.25 Million 479.1 Million 479.1 Million
Weighted Average Shares Outstanding (Diluted) 480.94 Million 474.21 Million 448.25 Million 479.1 Million 479.1 Million
Gross Margin 0.74 1.00 1.00 1.00 -
EBIT Margin -18.76 -130.52 -95.18 -92.53 -
Profit Margin -18.83 -135.06 -113.35 -144.81 -
EBITDA -569.86 Million -847.66 Million -589.99 Million -134.9 Million -68.42 Million
Earnings Before Tax Margin -20.34 -138.21 -98.80 -101.28 -

Income Statement Charts